Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;16(3):775-782.
doi: 10.1177/19322968221078884. Epub 2022 Feb 28.

Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report

Kevin T Nguyen  1 , Nicole Y Xu  1 , Bruce A Buckingham  2 , Sarnath Chattaraj  3 , Ohad Cohen  4 , Lutz Heinemann  5 , John Pickup  6 , Jannet Svensson  7 , Robert A Vigersky  3 , Jenise C Wong  8 , Ralph Ziegler  9
Affiliations

Improving the Patient Experience With Longer Wear Infusion Sets Symposium Report

Kevin T Nguyen et al. J Diabetes Sci Technol. 2022 May.

Abstract

Continuous subcutaneous insulin infusion (CSII) therapy is becoming increasingly popular. CSII provides convenient insulin delivery, precise dosing, easy adjustments for physical activity, stress, or illness, and integration with continuous glucose monitors in hybrid or other closed-loop systems. However, even as insulin pump hardware and software have advanced, technology for insulin infusion sets (IISs) has stayed relatively stagnant over time and is often referred to as the "Achilles heel" of CSII. To discuss barriers to insulin pump therapy and present information about advancements in, and results from clinical trials of extended wear IISs, Diabetes Technology Society virtually hosted the "Improving the Patient Experience with Longer Wear Infusion Sets Symposium" on December 1, 2021. The symposium featured experts in the field of IISs, including representatives from Steno Diabetes Center Copenhagen, University of California San Francisco, Stanford University, Medtronic Diabetes, and Science Consulting in Diabetes. The webinar's seven speakers covered (1) advancements in insulin pump therapy, (2) efficacy of longer wear infusion sets, and (3) innovations to reduce plastics and insulin waste.

Keywords: diabetes; infusion set; insulin; insulin pump; longer wear; waste.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: KTN and NYX have nothing relevant to disclose. BAB is on medical advisory boards for Convatec and Medtronic. BAB receives research support from the NIH, Medtronic, Insulet, Tandem, Beta Bionics, and Dexcom. SC is an employee of Medtronic. OC is an employee of Medtronic. LH is a consultant for a number of companies that are developing novel diagnostic and therapeutic options for diabetes treatment. He is a shareholder of the Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany. JP reports consultancy fees from Medtronic and BD. JS serves as an adviser to Medtronic and Novo Nordisk. She owns shares in Novo Nordisk and has received fees for speaking on behalf of Medtronic and Novo Nordisk. RAV is a full-time employee of Medtronic Diabetes. JCW has received research support from Dexcom, Inc and Tandem Diabetes Care. She is also a volunteer medical advisor and co-founder of Tidepool (for which she receives no compensation). RZ is on advisory boards of the following companies: Abbott, Lilly, Novo Nordisk and Roche. He has received speaking fees from Abbott, Dexcom, Glooko, Lilly, Menarini, Novo Nordisk and Roche.

References

    1. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66–72. doi: 10.1089/dia.2018.0384. - DOI - PMC - PubMed
    1. Heinemann L, Krinelke L. Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. J Diabetes Sci Technol. 2012;6(4):954–964. - PMC - PubMed
    1. Simic A, Schøndorff PK, Stumpe T, et al. Survival assessment of the extended-wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique. Diabetes Obes Metab. 2021;23(6):1402–1408. doi: 10.1111/dom.14337. - DOI - PMC - PubMed
    1. Bonato L, Taleb N, Gingras V, et al. Duration of catheter use in patients with diabetes using continuous subcutaneous insulin infusion: a review. Diabetes Technol Ther. 2018;20(7):506–515. doi: 10.1089/dia.2018.0110. - DOI - PubMed
    1. Medtronic secures FDA clearance for first ever infusion set that can be worn up to 7 days by people with diabetes. Medtronic News. July 16, 2021. https://news.medtronic.com/featured-stories?item=231. Accessed January 3, 2022.

Publication types